NCT05348642View on ClinicalTrials.gov

Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to IBS

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 21, 2022

Primary Completion Date

January 6, 2023

Study Completion Date

January 6, 2023

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

pasteurized A. muciniphila

pasteurized A. muciniphila - oral daily dose

DIETARY_SUPPLEMENT

placebo

Placebo = identical to verum regarding the form, size, taste, color and intake

Trial Locations (1)

13467

analyze & realize GmbH, Berlin

Sponsors
All Listed Sponsors
lead

A-Mansia Biotech S.A.

INDUSTRY

NCT05348642 - Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to IBS | Biotech Hunter | Biotech Hunter